Drug repositioning as an effective therapy for protease-activated receptor 2 inhibition.

Saqib, Uzma; Savai, Rajkumar; Liu, DongFang; Banerjee, Sreeparna; Baig, Mirza S

Saqib, Uzma; Savai, Rajkumar; Liu, DongFang; Banerjee, Sreeparna; Baig, Mirza S.

Afiliação

Saqib U; Discipline of Chemistry, Indian Institute of Technology Indore (IITI), Indore, India.
Savai R; Department of Lung Development and Remodeling, Member of the German Center for Lung Research (DZL), Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.
Liu D; Center for Inflammation & Epigenetics, Houston Methodist Research Institute, Houston, Texas.
Banerjee S; Department of Microbiology and Immunology, Weill Cornell Medical College, Cornell University, New York.
Baig MS; Department of Biological Sciences, Orta Dogu Teknik Üniversitesi (ODTU/METU), Ankara, Turkey.

J Cell Biochem ; 120(2): 1522-1526, 2019 Feb.

Article em En | MEDLINE | ID: mdl-30370939

Palavras-chave

antagonist; drug repositioning; inflammation; proteinase-activated receptor 2

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Cell Biochem Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Índia País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google